In-vivo Effectiveness of Adapalene 0.1%/ Benzoyl Peroxide 2.5% Gel on Antibiotic-sensitive and Resistant Propionibacterium acnes
by James J. Leyden, MD, Department of Dermatology, University of Pennsylvania, Philadelphia, and the Skin Study Center, KGL, Inc., Broomall, Pennsylvania; Norman Preston, PhD; Galderma Laboratories, L.P., Fort Worth, Texas; Cris Osborn, PhD; Galderma Laboratories, L.P.; Ronald W. Gottschalk, MD, Galderma Laboratories, L.P. Disclosure: Dr. Leyden is a consultant for Galderma Laboratories, L.P. Drs. Preston, [...]
Message from the Section Editor As the Section Editor of the “Aesthetic Update” section of The Journal of Clinical and Aesthetic Dermatology (JCAD), it is my extreme privilege to introduce a new series of guest submissions. We have invited some of the leading experts in aesthetic dermatology to contribute to the Aesthtic Update in 2011, [...]
James Q. Del Rosso, DO, Dermatology Residency Program Director, Valley Hospital Medical Center, Las Vegas, Nevada Disclosure: Dr. Del Rosso is a consultant, speaker, and/or researcher for Allergan, Coria, Galderma, Graceway, Intendis, Leo Pharma, Medicis, Onset Therapeutics, Ortho Dermatology, PharmaDerm, Promius, Quinnova, Ranbaxy, SkinMedica, Stiefel, Triax, Unilever, and Warner Chilcott.